Literature DB >> 19784743

Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer.

Hajimu Gotoh1, Naoki Kanomata, Masahiro Yoshimura, Yoshiharu Ohno, Takuya Moriya, Chiho Ohbayashi.   

Abstract

Nodal staging is a crucial factor in choosing the treatment option for non-small cell lung cancer (NSCLC). However, so far as we know, a computer-based histomorphometric analysis of lymph nodes in NSCLC has never been developed. We studied 299 surgically resected lymph nodes from 108 patients with NSCLC. Microscopic digital images were analyzed with Scion Image software. Seventy lymph nodes had at least one metastatic focus. The metastasis occupancy area per node ranged from 0.01 to 209.58 mm(2) (mean, 29.58 +/- 5.87 mm(2)). The metastasis occupancy ratio ranged from 0.01% to 100% (mean, 48.70% +/- 42.10%). The short-axis diameter of malignant lymph nodes was significantly longer than that of benign lymph nodes (P = 0.0002). The average metastasis occupancy area in the regional lymph nodes of NSCLC is quite small. Various inflammatory conditions can result in a false-positive diagnosis when these techniques are used. Studies that combine analysis of primary tumor size and serum carcinoembryonic antigen (CEA) levels with imaging methods should be considered. Finally, the use of mediastinoscopy or video-assisted thoracoscopic surgery is encouraged in determining the exact nodal status in NSCLC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784743     DOI: 10.1007/s00795-009-0455-x

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  36 in total

1.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

Authors:  N C Gupta; G M Graeber; H A Bishop
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

2.  A rare case of coexistence of pulmonary adenocarcinoma with Langerhans' cell histiocytosis.

Authors:  Yuji Ohtsuki; Masashi Uomoto; Yasuki Hachisuka; Miyuki Kato; Mitsuko Iguchi; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2008-09-20       Impact factor: 2.309

3.  Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

Authors:  A Guhlmann; M Storck; J Kotzerke; F Moog; L Sunder-Plassmann; S N Reske
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

4.  Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer.

Authors:  K Suzuki; K Nagai; J Yoshida; M Nishimura; K Takahashi; Y Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

5.  Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging.

Authors:  K M Kerr; D Lamb; C G Wathen; W S Walker; N J Douglas
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

6.  Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.

Authors:  R Kubota; K Kubota; S Yamada; M Tada; T Ido; N Tamahashi
Journal:  J Nucl Med       Date:  1994-06       Impact factor: 10.057

7.  Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro.

Authors:  Jan Thiess Deichen; Olaf Prante; Michaela Gack; Kristin Schmiedehausen; Torsten Kuwert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-05       Impact factor: 9.236

8.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Authors:  R Rosell; J Gómez-Codina; C Camps; J Maestre; J Padille; A Cantó; J L Mate; S Li; J Roig; A Olazábal
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Lung cancer. Invasive staging: the guidelines.

Authors:  Frank C Detterbeck; Malcolm M DeCamp; Leslie J Kohman; Gerard A Silvestri
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

View more
  2 in total

1.  The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.

Authors:  Hongxin Zhang; Yuhui Yin; Lan Zhang; Xiangyu Zheng; Dongling Gao; Kuisheng Chen; Yunhan Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-06       Impact factor: 4.553

2.  Nodal size ranking as a predictor of mediastinal involvement in clinical early-stage non-small cell lung cancer.

Authors:  Cristina Caupena; Roser Costa; Francisco Pérez-Ochoa; Sergi Call; Àngels Jaen; Ramón Rami-Porta; Carme Obiols; Lluis Esteban; Raquel Albero-González; Luis Antonio Luizaga; Mireia Serra; Josep Belda; Xavier Tarroch; José Sanz-Santos
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.